Eikon Therapeutics
Eikon Therapeutics Raises $350.7M in Series D
Quick Facts
Eikon Therapeutics Raises $350.7M in Series D
Eikon Therapeutics has successfully raised $350.7M in a Series D at a $3B valuation led by Andreessen Horowitz Bio, ARCH Venture Partners.
Company Overview
Eikon Therapeutics is a HealthTech company headquartered in Hayward, CA, founded in 2019 with 200+ employees.
Drug discovery using advanced microscopy
Fundraising Details
- Amount Raised: $350.7M
- Round Type: Series D
- Valuation: $3B
- Date: 2025-02-01
- Investors: Andreessen Horowitz Bio, ARCH Venture Partners
About Eikon Therapeutics
Drug discovery using advanced microscopy The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Hayward, CA
- Founded: 2019
- Team Size: 200+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Eikon Therapeutics's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Eikon Therapeutics's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $3B valuation marks an important milestone for Eikon Therapeutics, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Eikon Therapeutics is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2025-02-01. For more information about Eikon Therapeutics, visit their headquarters at Hayward, CA.
About the Author
Related Company Reports
Harvey AI Raises $160 million in Series F
Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.
7AI Raises $130 million in Series A
7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.
TRIANA Biomedicines Raises $120 million in Series B
TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.